Local Therapy Can Enhance the Prognosis of Certain Patients with Pathologically Diagnosed Neuroendocrine Prostate Carcinoma

Local Therapy Can Enhance the Prognosis of Certain Patients with Pathologically Diagnosed Neuroendocrine Prostate Carcinoma

Neuroendocrine prostate cancer (NEPC) has a poor prognosis. We performed a retrospective analysis of the factors contributing to survival in patients with histologically diagnosed NEPC. Patients pathologically diagnosed with NEPC between 2007 and 2018 were retrospectively analyzed. Overall survival...

Full description

Saved in:
Bibliographic Details
Main Authors: Shoichi Kimura, Naoki Terada, Shinnya Soumiya, Takayuki Goto, Hiromitsu Negoro, Shoichiro Mukai, Osamu Ogawa, Shusuke Akamatsu, Takashi Kobayashi, Atsuro Sawada, Toshiyuki Kamoto
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Life
Subjects:
neuroendocrine prostate carcinoma
local therapy
prostate cancer
Online Access:https://www.mdpi.com/2075-1729/15/5/797
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items